CA2306086A1 - Use of thiazolidinediones for the treatment of hyperglycaemia - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia Download PDF

Info

Publication number
CA2306086A1
CA2306086A1 CA002306086A CA2306086A CA2306086A1 CA 2306086 A1 CA2306086 A1 CA 2306086A1 CA 002306086 A CA002306086 A CA 002306086A CA 2306086 A CA2306086 A CA 2306086A CA 2306086 A1 CA2306086 A1 CA 2306086A1
Authority
CA
Canada
Prior art keywords
hyperglycaemia
range
glucose levels
plasma glucose
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002306086A
Other languages
English (en)
French (fr)
Inventor
Robert Edwin Buckingham
Stephen Alistair Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2306086A1 publication Critical patent/CA2306086A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
CA002306086A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia Abandoned CA2306086A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
GB9721693.1 1997-10-13
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number Publication Date
CA2306086A1 true CA2306086A1 (en) 1999-04-22

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002306086A Abandoned CA2306086A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (no)
JP (1) JP2001519382A (no)
KR (1) KR20010024481A (no)
CN (1) CN1281359A (no)
AP (1) AP2000001787A0 (no)
AU (1) AU9547098A (no)
BG (1) BG104404A (no)
BR (1) BR9815219A (no)
CA (1) CA2306086A1 (no)
CZ (1) CZ20001297A3 (no)
EA (1) EA002659B1 (no)
GB (1) GB9721693D0 (no)
HR (1) HRP20000255A2 (no)
HU (1) HUP0003922A3 (no)
ID (1) ID24521A (no)
IL (1) IL135513A0 (no)
NO (1) NO20001898L (no)
NZ (1) NZ503862A (no)
OA (1) OA11683A (no)
PL (1) PL339813A1 (no)
SK (1) SK5312000A3 (no)
TR (1) TR200000958T2 (no)
WO (1) WO1999018943A1 (no)
YU (1) YU28800A (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
IL135513A0 (en) 2001-05-20
NO20001898L (no) 2000-06-09
SK5312000A3 (en) 2000-09-12
EA200000419A1 (ru) 2000-10-30
HUP0003922A2 (hu) 2001-10-28
BG104404A (bg) 2000-12-29
NZ503862A (en) 2003-01-31
OA11683A (en) 2005-01-12
TR200000958T2 (tr) 2000-08-21
CN1281359A (zh) 2001-01-24
WO1999018943A1 (en) 1999-04-22
EA002659B1 (ru) 2002-08-29
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
PL339813A1 (en) 2001-01-02
EP1023056A1 (en) 2000-08-02
BR9815219A (pt) 2001-01-02
NO20001898D0 (no) 2000-04-12
JP2001519382A (ja) 2001-10-23
AU9547098A (en) 1999-05-03
YU28800A (sh) 2003-02-28
HUP0003922A3 (en) 2001-12-28
CZ20001297A3 (cs) 2001-08-15
KR20010024481A (ko) 2001-03-26
ID24521A (id) 2000-07-20
HRP20000255A2 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
AU8448898A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
CA2297115C (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
CA2297133A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
CA2294134A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
US20020137773A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
US20030069283A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
CA2305289A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
CA2306086A1 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
US20020045649A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
AU4586902A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
AU4587002A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00003633A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA00003634A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
US20020123514A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
CA2549864A1 (en) Treatment of diabetes with thiazolidinedione and metformin
MXPA99012078A (en) Treatment of diabetes with thiazolidinedione and metformin

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued